New hope for easing Autism's rigid routines?
NCT ID NCT05999240
Summary
This study is testing if a medication called pimavanserin can help reduce rigid, repetitive behaviors in teens and adults with autism. About 30 participants will first try a single dose of either the drug or a placebo, then all will take the drug for six weeks. The main goal is to see if the drug is safe and if it helps make rigid behaviors less severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Autism and the Developing Brain
RECRUITINGWhite Plains, New York, 10605, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wakarusa Research Facility
RECRUITINGLawrence, Kansas, 66049, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.